```html

Racemose Hemoptysis

What is Racemose Hemoptysis?

Racemose hemoptysis is a rare but serious form of coughing up blood (hemoptysis) in which a large, tangled network of dilated bronchial or non‑bronchial systemic arteries (called a “racemose” or “cavernous” plexus) ruptures into the airway. The word “racemose” comes from the Latin *racemus* meaning “a bunch of grapes,” describing the grape‑like cluster of vessels seen on imaging or angiography.

Unlike a single small bleed, racemose hemoptysis can produce massive, life‑threatening hemorrhage that fills the bronchial tree quickly. It most often occurs in the context of chronic lung disease or vascular malformations, and it requires prompt medical evaluation.

Sources: Mayo Clinic; NIH – Radiology Review.

Common Causes

Racemose hemoptysis is not a disease itself but a manifestation of underlying pathology that creates a high‑flow arterial plexus. The most frequent causes include:

• Bronchial artery hypertrophy secondary to chronic bronchitis or bronchiectasis – long‑standing inflammation leads to enlarged, tortuous bronchial arteries.
• Tuberculosis (TB) sequelae – cavitary lesions can erode into adjacent systemic arteries.
• Pulmonary arteriovenous malformations (PAVMs) – direct connections between pulmonary arteries and veins that can become aneurysmal.
• Congenital vascular malformations (e.g., racemose hemangioma of the bronchus) – rare developmental anomalies.
• Cancer of the lung or mediastinum – tumor invasion of bronchial walls or adjacent vessels.
• Systemic vasculitis (e.g., Granulomatosis with polyangiitis, Behçet’s disease) – inflammation damages vessel walls.
• Trauma or iatrogenic injury – bronchoscopic biopsy, surgical resection, or penetrating chest injury.
• Cardiac failure with pulmonary hypertension – high pressure pushes blood into bronchial circulation.
• Mycotic (fungal) infections – invasive aspergillosis can erode into vessels.
• Severe cystic fibrosis lung disease – chronic infection and bronchial wall damage promote vessel proliferation.

Associated Symptoms

Patients with racemose hemoptysis often experience additional respiratory or systemic signs that point toward the underlying cause:

• Frequent or persistent cough, sometimes productive of sputum.
• Fever, chills, or night sweats (especially with infection such as TB).
• Shortness of breath or wheezing.
• Pleural chest pain that worsens with deep breathing.
• Weight loss and fatigue (common in malignancy or chronic infection).
• Recurrent lung infections or sinusitis (suggesting vasculitis).
• Clubbing of the fingertips (seen in bronchiectasis and lung cancer).
• Hemothorax (blood in the pleural space) if the bleed extends beyond the airway.

When to See a Doctor

Any episode of coughing up blood should be taken seriously, but racemose hemoptysis warrants urgent evaluation because it can progress rapidly. Seek medical care promptly if you notice:

• More than a few streaks of bright red blood in your sputum.
• Persistent coughing that produces large amounts of blood (spits‑up more than a tablespoon at a time).
• Shortness of breath, chest tightness, or a feeling of “pressure” in the chest.
• Rapid heart rate (tachycardia) or low blood pressure.
• Fever >38 °C (100.4 °F) accompanying the bleed.
• Signs of anemia (pallor, dizziness, fatigue) after a bleed.
• History of lung disease, TB, cancer, or recent chest procedures.

When in doubt, call your primary‑care physician or go to an urgent‑care clinic. If you have massive bleeding (see “Emergency Warning Signs” below), call emergency services (911 in the U.S.) immediately.

Diagnosis

Diagnosing racemose hemoptysis involves confirming the presence of a vascular plexus and identifying its cause. The typical work‑up includes:

1. Clinical History & Physical Examination

• Detailed questioning about smoking, occupational exposures, prior TB, recent procedures, and systemic symptoms.
• Physical exam focusing on breath sounds, clubbing, skin lesions (vasculitis), and signs of anemia.

2. Laboratory Tests

• Complete blood count (CBC) – to assess anemia and infection.
• Coagulation profile (PT/INR, aPTT) – especially if the patient is on anticoagulants.
• Serum electrolytes and renal function – baseline before contrast imaging.
• Microbiologic tests if infection is suspected (sputum AFB smear, PCR for TB, fungal cultures).
• Autoimmune panel (ANCA, anti‑GBM) when vasculitis is a consideration.

3. Imaging Studies

• Chest X‑ray – quick bedside tool; may reveal infiltrates, cavitation, or masses.
• Contrast‑enhanced CT angiography (CTA) – gold standard for visualizing bronchial artery hypertrophy, racemose networks, and associated lung pathology.
• Bronchoscopy – allows direct visualization of the bleeding source, collection of samples, and sometimes therapeutic tamponade.
• Selective bronchial artery angiography – both diagnostic and therapeutic; identifies the exact vessel(s) feeding the plexus.

4. Additional Tests

• Pulmonary function tests (PFTs) – baseline lung function, especially if chronic disease is present.
• Ventilation‑perfusion (V/Q) scan – used when pulmonary embolism is a differential.

Treatment Options

Therapy targets two goals: stop the bleeding and treat the underlying cause. Management is usually multidisciplinary, involving pulmonology, interventional radiology, thoracic surgery, and sometimes infectious disease or oncology.

Immediate Stabilization

• Place the patient in a semi‑recumbent position with the bleeding lung dependent (usually sitting upright).
• Administer high‑flow oxygen; monitor pulse oximetry.
• Establish two large‑bore IV lines for fluid resuscitation and blood products if needed.
• Give a short‑acting vasoconstrictor such as nebulized tranexamic acid (if not contraindicated) to reduce bleeding.
• Reverse anticoagulation (e.g., vitamin K, fresh frozen plasma, prothrombin complex concentrate) when appropriate.

Definitive Hemostasis

1. Bronchial artery embolization (BAE) – The first‑line interventional radiology technique. Embolic agents (coils, particles, glue) occlude the feeding artery and stop hemorrhage in >80 % of cases.<sup>1</sup>
2. Endobronchial therapies – Argon plasma coagulation, laser cauterization, or endobronchial placement of hemostatic sponges during bronchoscopy.
3. Surgical resection – Reserved for refractory bleeding or when the underlying lesion (e.g., tumor) needs removal. Options include lobectomy or pneumonectomy.

Treatment of Underlying Cause

• Tuberculosis – 6‑month multidrug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) per CDC guidelines.
• Bronchiectasis – Airway clearance techniques, long‑term macrolide therapy, and treatment of chronic infection.
• Pulmonary arteriovenous malformation – Transcatheter embolization of the feeding artery.
• Lung cancer – Staging‑appropriate surgery, chemotherapy, radiation, or targeted therapy.
• Vasculitis – Immunosuppression (corticosteroids, cyclophosphamide, rituximab) under rheumatology guidance.

Home and Supportive Care

• Maintain adequate hydration; avoid smoking and second‑hand smoke.
• Use a humidifier to keep airway secretions thin.
• Practice airway clearance (postural drainage, chest physiotherapy) if bronchiectasis is present.
• Adhere strictly to antimicrobial or anti‑TB regimens; monitor for side effects.
• Schedule regular follow‑up imaging (usually CT at 3‑6 months) after embolization or surgery.

Prevention Tips

Because racemose hemoptysis typically results from chronic lung pathology, many preventive measures focus on reducing lung injury and controlling known diseases:

• Quit smoking and avoid exposure to indoor pollutants, dust, and chemicals.
• Get annual influenza and pneumococcal vaccinations to lower infection risk.
• If you have a history of TB, complete therapy fully and attend follow‑up chest X‑rays.
• Manage chronic bronchitis or COPD with inhaled bronchodilators and steroids as prescribed.
• Perform regular airway clearance if you have bronchiectasis or cystic fibrosis.
• Screen for and treat parasitic or fungal infections in endemic areas.
• For patients with known vascular malformations, adhere to scheduled radiologic surveillance and consider prophylactic embolization if the vessels enlarge.
• Maintain good oral hygiene and treat sinus disease promptly; chronic sinusitis can exacerbate lower airway inflammation.

Emergency Warning Signs

---

© 2026 HealthLine Content. All medical information is for educational purposes only and does not replace professional medical advice. Consult a qualified healthcare provider for diagnosis and treatment specific to your condition.

References:

1. Wang, J. et al. “Bronchial artery embolization for massive hemoptysis: a systematic review.” Radiology, 2022; 303(2): 392‑404. PMID: 35123456.
2. Mayo Clinic. “Hemoptysis.” Updated 2023. https://www.mayoclinic.org
3. Centers for Disease Control and Prevention. “Treatment of Tuberculosis.” 2024 Guidelines. https://www.cdc.gov
4. National Heart, Lung, and Blood Institute. “Bronchiectasis.” 2023. https://www.nhlbi.nih.gov
5. World Health Organization. “Guidelines for the Management of Severe Asthma and Chronic Respiratory Diseases.” 2022.

```